Results 241 to 246 of about 60,957 (246)

[JAK2, CALR].

Rinsho byori. The Japanese journal of clinical pathology, 2019
Representative diseases of BCR/ABL-negative myeloproliferative neoplasms (MPN) are polycythemia vera (PV), essential thrombocytosis (ET), and primary myelofibrosis (PMF). It was reported in 2005 that there is a common genetic mutation in Exon 14 of the JAK2 gene in MPN cases.
openaire   +1 more source

???????????????? ????????-?????????????? ?????? ?????????????????? ?????????????? V617F ???????? jak2 ?? ???????????? ???? ???????????????? ?????????????????????????????????????? ????????????????????????

2011
?????????????? V617F ???????? jak2 ???????????????? ???????????? ?????????????????????????????? ?????????????????? ?????? ?????????????????????? ???????????????????????????????????????? ????????????????????????. ???????????????????? ????????-?????????????? ?????? ?????????????????? ?????????????? ?? ?????????????? ???????????? ??????????????-???????????
openaire   +1 more source

???????????????????????? ???????????????? ?????????????????????????? ?????????????????????? ???????????????????? ?????????????????????? ?? ?????????????????? ?????????????????????????? ???? ???? ??????????????? ???? ?????????????????? ?????????????? JAK2 V617F

2018
????????: ?????????????????????? ???????????????? ?????????????????????????? ?????????? ???????????????????? ?????????????????????? (????) ???? ?????????????????? ?????????????????????????? (????), ???????????? ???? ??????????????? ?? ?????????????????? ?????????????? JAK2 V617F, ???????????????????? ???????????????????? ???? ??????????????????????????
openaire   +1 more source

JAK2

2008
openaire   +1 more source

JAK2 Fusion Positive

2020
openaire   +1 more source

JAK2 NP_004963.1:p.R938L

2020
openaire   +1 more source